Cardiometabolic effects of SGLT2 inhibitors on polycystic ovary syndrome

Ioannis Lempesis(Brigham and Women's Hospital), Damianos G. Kokkinidis(Memorial Hospital of South Bend), Samuel J. Apple(Jacobi Medical Center), Μaria Dalamaga(National and Kapodistrian University of Athens), Leonidas Palaiodimos(Albert Einstein College of Medicine), Dimitrios Rafail Kalaitzopoulos(University Hospital Zurich), Gustavo Duarte(Jacobi Medical Center)
Diabetes/Metabolism Research and Reviews
July 1, 2023
10.1002/dmrr.3682
Cited by 22

Related Papers

Obesity and cancer risk: Emerging biological mechanisms and perspectives
|Metabolism|2018|1.6k
Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York
|Metabolism|2020|901
The Role of Adiponectin in Cancer: A Review of Current Evidence
|Endocrine Reviews|2012|635
Adiponectin and Breast Cancer Risk
|The Journal of Clinical Endocrinology & Metabolism|2004|535
Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity
|JAMA Cardiology|2019|418